The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

Cerebras Systems co-founder and Chief Executive Andrew Feldman likes to compare the current state of AI to the dial-up era of ...

Bupropion Hydrochloride Extended-Release Tablets USP (SR) are bioequivalent and therapeutically equivalent to Wellbutrin SR ...

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...